0000021665-26-000025
SEC filingColgate-Palmolive held its Annual Meeting of Stockholders on May 8, 2026, where ten director nominees were elected, the appointment of PricewaterhouseCoopers LLP as independent auditor was ratified, advisory approval of executive compensation was obtained, and two stockholder proposals—on DEI and an independent board chairman—were rejected.
The 2026 Annual Meeting reflects stable board governance with full re-election of the slate, albeit with meaningful opposition to several directors—most notably John T. Cahill and Noel Wallace—suggesting investor scrutiny over strategic performance or oversight effectiveness. The clean ratification of PwC signals audit continuity and lack of accounting controversy. While the say-on-pay vote passed, the 43 million 'Against' votes and 64 million broker non-votes indicate persistent concerns about executive compensation alignment, particularly amid ongoing margin pressure in consumer staples. The overwhelming rejection of the DEI-related proposal affirms broad shareholder support for existing board diversity frameworks, whereas the failure of the independent chairman proposal—despite growing governance best-practice expectations—reinforces Colgate’s longstanding unified leadership model. Collectively, these outcomes point to a board viewed as competent and aligned on strategy and culture, yet facing increasing accountability on pay and leadership structure.